Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,241 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genomic ALK alterations in primary and relapsed neuroblastoma.
Rosswog C, Fassunke J, Ernst A, Schömig-Markiefka B, Merkelbach-Bruse S, Bartenhagen C, Cartolano M, Ackermann S, Theissen J, Blattner-Johnson M, Jones B, Schramm K, Altmüller J, Nürnberg P, Ortmann M, Berthold F, Peifer M, Büttner R, Westermann F, Schulte JH, Simon T, Hero B, Fischer M. Rosswog C, et al. Among authors: ernst a. Br J Cancer. 2023 Apr;128(8):1559-1571. doi: 10.1038/s41416-023-02208-y. Epub 2023 Feb 17. Br J Cancer. 2023. PMID: 36807339 Free PMC article.
Long-term outcomes of the GPOH NB97 trial for children with high-risk neuroblastoma comparing high-dose chemotherapy with autologous stem cell transplantation and oral chemotherapy as consolidation.
Berthold F, Ernst A, Hero B, Klingebiel T, Kremens B, Schilling FH, Simon T. Berthold F, et al. Among authors: ernst a. Br J Cancer. 2018 Aug;119(3):282-290. doi: 10.1038/s41416-018-0169-8. Epub 2018 Jul 11. Br J Cancer. 2018. PMID: 29991700 Free PMC article. Clinical Trial.
Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HR.
Berthold F, Faldum A, Ernst A, Boos J, Dilloo D, Eggert A, Fischer M, Frühwald M, Henze G, Klingebiel T, Kratz C, Kremens B, Krug B, Leuschner I, Schmidt M, Schmidt R, Schumacher-Kuckelkorn R, von Schweinitz D, Schilling FH, Theissen J, Volland R, Hero B, Simon T. Berthold F, et al. Among authors: ernst a. Ann Oncol. 2020 Mar;31(3):422-429. doi: 10.1016/j.annonc.2019.11.011. Epub 2020 Jan 24. Ann Oncol. 2020. PMID: 32067684 Free article. Clinical Trial.
The reliability of bone marrow cytology as response criterion in metastatic neuroblastoma.
Schumacher-Kuckelkorn R, Atra A, Belli ML, den Engelsman G, Fréneaux P, Gauthier A, Heijlaerts-Klever A, Scuderi F, Senent Peris L, Tewari S, Zapletal O, Ernst A, Berthold F. Schumacher-Kuckelkorn R, et al. Among authors: ernst a. Pediatr Blood Cancer. 2021 Mar;68(3):e28819. doi: 10.1002/pbc.28819. Epub 2020 Nov 27. Pediatr Blood Cancer. 2021. PMID: 33245195
Clinical and molecular characterization of patients with stage 4(M) neuroblastoma aged less than 18 months without MYCN amplification.
Berthold F, Rosswog C, Christiansen H, Frühwald M, Hemstedt N, Klingebiel T, Fröhlich B, Schilling FH, Schmid I, Simon T, Hero B, Fischer M, Ernst A. Berthold F, et al. Among authors: ernst a. Pediatr Blood Cancer. 2021 Aug;68(8):e29038. doi: 10.1002/pbc.29038. Epub 2021 Apr 7. Pediatr Blood Cancer. 2021. PMID: 33826231
1,241 results